Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala

author
created [InstanceEdit:9669160] Rothfels, Karen, 2019-12-02
dbId 9669165
displayName Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala
journal Mol. Cancer Ther.
pages 2008-15
pubMedIdentifier 16373716
schemaClass LiteratureReference
title Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala
url http://www.ncbi.nlm.nih.gov/pubmed/16373716
volume 4
year 2005
Cite Us!